A Multi-Center, Open-Label Study

Clinical trial NCT01468259 · WITHDRAWN

Trial details

NCT number: NCT01468259
Sponsor: Chelsea Therapeutics
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Disease End Stage Renal Disease

Start date: 2012-10-01
Primary completion: 2012-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.